Alto Neuroscience (NYSE:ANRO) shares nosedived 66% Wednesday morning, the first trading session, after the company announced its psychiatric drug ALTO-100 had failed a key clinical study. After ...

Alto Neuroscience hit a bum note in an early test of its precision neuropsychiatry model. A phase 2b trial of Alto’s lead drug candidate in depression missed its primary and key secondary ...

– Strong cash position expected to fund Alto’s planned operations through multiple near-term milestones across pipeline of independent programs – MOUNTAIN VIEW, Calif., October 22, 2024 ...

An adaptable saxophonist and arranger, Dom has worked in a wide range of styles; from classical solo engagements on soprano saxophone with the Oxford Pro Musica Singers to session work on alto and ...

Only made for fuel efficiency. iske ilawa na to value of money hy. plastic or paper ki tarha built ki gae hy. no doubt fuel economy dekhi jaye to prius/aqua leine say better hy aap alto lay lain. i ...